Hauptseite > Publikationsdatenbank > CT-Based Prediction of Liver Function and Post-PVE Hypertrophy Using an Artificial Neural Network > print |
001 | 894190 | ||
005 | 20211025171506.0 | ||
024 | 7 | _ | |a 10.3390/jcm10143079 |2 doi |
024 | 7 | _ | |a 2128/28757 |2 Handle |
024 | 7 | _ | |a 34300246 |2 pmid |
024 | 7 | _ | |a WOS:000676306200001 |2 WOS |
037 | _ | _ | |a FZJ-2021-03081 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Heise, Daniel |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
245 | _ | _ | |a CT-Based Prediction of Liver Function and Post-PVE Hypertrophy Using an Artificial Neural Network |
260 | _ | _ | |a Basel |c 2021 |b MDPI |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1633956240_10602 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Background: This study aimed to evaluate whether hypertrophy after portal vein embolization (PVE) and maximum liver function capacity (LiMAx) are predictable by an artificial neural network (ANN) model based on computed tomography (CT) texture features.Methods: We report a retrospective analysis on 118 patients undergoing preoperative assessment by CT before and after PVE for subsequent extended liver resection due to a malignant tumor at RWTH Aachen University Hospital. The LiMAx test was carried out in a subgroup of 55 patients prior to PVE. Associations between CT texture features and hypertrophy as well as liver function were assessed by a multilayer perceptron ANN model.Results: Liver volumetry showed a median hypertrophy degree of 33.9% (16.5-60.4%) after PVE. Non-response, defined as a hypertrophy grade lower than 25%, was found in 36.5% (43/118) of the cases. The ANN prediction of the hypertrophy response showed a sensitivity of 95.8%, specificity of 44.4% and overall prediction accuracy of 74.6% (p < 0.001). The observed median LiMAx was 327 (248-433) μg/kg/h and was strongly correlated with the predicted LiMAx (R2 = 0.89).Conclusion: Our study shows that an ANN model based on CT texture features is able to predict the maximum liver function capacity and may be useful to assess potential hypertrophy after performing PVE.Keywords: artificial neural network; computed tomography; liver function; liver volume; portal vein embolization. |
536 | _ | _ | |a 5254 - Neuroscientific Data Analytics and AI (POF4-525) |0 G:(DE-HGF)POF4-5254 |c POF4-525 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
700 | 1 | _ | |a Schulze-Hagen, Maximilian |0 0000-0002-9182-2688 |b 1 |
700 | 1 | _ | |a Bednarsch, Jan |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Eickhoff, Roman |0 P:(DE-HGF)0 |b 3 |
700 | 1 | _ | |a Kroh, Andreas |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Bruners, Philipp |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Eickhoff, Simon B. |0 P:(DE-Juel1)131678 |b 6 |
700 | 1 | _ | |a Brecheisen, Ralph |0 0000-0001-9937-2602 |b 7 |
700 | 1 | _ | |a Ulmer, Florian |0 P:(DE-HGF)0 |b 8 |
700 | 1 | _ | |a Neumann, Ulf Peter |0 P:(DE-HGF)0 |b 9 |
773 | _ | _ | |a 10.3390/jcm10143079 |g Vol. 10, no. 14, p. 3079 - |0 PERI:(DE-600)2662592-1 |n 14 |p 3079 - |t Journal of Clinical Medicine |v 10 |y 2021 |x 2077-0383 |
856 | 4 | _ | |y OpenAccess |u https://juser.fz-juelich.de/record/894190/files/Heise.D_.pdf |
856 | 4 | _ | |y OpenAccess |u https://juser.fz-juelich.de/record/894190/files/jcm-10-03079.pdf |
909 | C | O | |o oai:juser.fz-juelich.de:894190 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 6 |6 P:(DE-Juel1)131678 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5254 |x 0 |
914 | 1 | _ | |y 2021 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-05-04 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-05-04 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-05-04 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J CLIN MED : 2019 |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2021-05-04 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2021-05-04 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2021-05-04 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-05-04 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-05-04 |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)INM-7-20090406 |k INM-7 |l Gehirn & Verhalten |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-Juel1)INM-7-20090406 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|